Stonebridge Capital Advisors’s Axcelis ACLS Stock Holding History

Stonebridge Capital Advisors’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7	Closed	–	–	961
2022 Q3	$0	Buy	+7	New	+$452	﹤0.01%	992

Other funds holding ACLS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stonebridge Capital Advisors's ACLS Position: Q4 2022 in Review

Stonebridge Capital Advisors sold out of Axcelis (ACLS) in Q4 2022, closing a stake of 7 shares.

Stonebridge Capital Advisors first reported a position in ACLS in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 327 funds tracked by Wall St. Rank hold ACLS as of Q4 2022.

Stonebridge Capital Advisors reported no remaining Axcelis position as of Q4 2022 after selling out during the quarter.
Stonebridge Capital Advisors sold 7 Axcelis shares in Q4 2022.
Stonebridge Capital Advisors first reported a position in Axcelis in Q3 2022 and held it in 1 quarter.
Stonebridge Capital Advisors's Axcelis position peaked at $0 in Q3 2022.
327 funds tracked by Wall St. Rank held Axcelis as of Q4 2022.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.